TABLE 2.
Joinpoint regression analysis for ASIR and ASMR of viral hepatitis in China, 1990–2019.
| 1990–2019 |
Period 1 |
Period 2 |
Period 3 |
|||||
| Period | AAPC | Period | APC | Period | APC | Period | APC | |
| Total | 1990–2019 | −1.9 (−1.9, −1.8) | 1990–1997 | −1.3 (−1.4, −1.2) | 1997–2010 | −2.0 (−2.0, −1.9) | 2010–2019 | −2.2 (−2.3, −2.1) |
| Sex | ||||||||
| Male | 1990–2019 | −1.8 (−1.8, −1.7) | 1990–1995 | −1.2 (−1.4, −1.1) | 1995–2000 | −1.4 (−1.7, −1.2) | 2000–2019 | −2.0 (−2.0, −2.0) |
| Female | 1990–2019 | −2.0 (−2.1, −2.0) | 1990–1995 | −1.2 (−1.4, −1.0) | 1995–2010 | −2.1 (−2.1, −2.1) | 2010–2019 | −2.3 (−2.4, −2.2) |
| Etiology | ||||||||
| HAV | 1990–2019 | −1.9 (−2.0, −1.8) | 1990–2001 | −2.6 (−2.8, −2.5) | 2001–2013 | −1.8 (−2.0, −1.7) | 2013–2019 | −0.8 (−1.2, −0.4) |
| HBV | 1990–2019 | −1.9 (−1.9, −1.8) | 1990–2000 | −0.4 (−0.5, −0.3) | 2000–2012 | −2.2 (−2.2, −2.1) | 2012–2019 | −3.4 (−3.5, −3.2) |
| HCV | 1990–2019 | −2.6 (−3.2, −2.0) | 1990–2004 | −8.2 (−8.6, −7.8) | 2004–2014 | −0.9 (−2.1,0.3) | 2014–2019 | 10.9 (8.1,13.8) |
| HEV | 1990–2019 | −1.8 (−1.8, −1.7) | 1990–1995 | −1.2 (−1.5, −0.9) | 1995–2014 | −2.2 (−2.2, −2.1) | 2014–2019 | −0.8 (−1.1, −0.4) |
| Total | 1990–2019 | −7.1 (−7.4, −6.7) | 1990–1999 | −7.4 (−7.8, −7.0) | 1999–2007 | −13.7 (−14.6, −12.9) | 2007–2019 | −2.1 (−2.7, −1.5) |
| Sex | ||||||||
| Male | 1990–2019 | −6.8 (−7.1, −6.4) | 1990–2000 | −6.8 (−7.1, −6.5) | 2000–2006 | −15.0 (−16.3, −13.7) | 2006–2019 | −2.6 (−3.1, −2.2) |
| Female | 1990–2019 | −7.9 (−8.3, −7.5) | 1990–1998 | −8.6 (−9.1, −8.1) | 1998–2007 | −14.4 (−15.2, −13.6) | 2007–2019 | −2.2 (−2.9, −1.4) |
| Etiology | ||||||||
| HAV | 1990–2019 | −10.6 (−11.1, −10.1) | 1990–1999 | −11.0 (−11.5, −10.6) | 1999–2008 | −17.0 (−18.0, −16.1) | 2008–2019 | −4.5 (−5.6, −3.4) |
| HBV | 1990–2019 | −5.3 (−5.6, −4.9) | 1990–2000 | −5.0 (−5.4, −4.7) | 2000–2006 | −13.6 (−15.0, −12.3) | 2006–2019 | −1.3 (−1.8, −0.8) |
| HCV | 1990–2019 | −9.0 (−9.4, −8.5) | 1990–1999 | −6.1 (−6.6, −5.7) | 1999–2009 | −15.8 (−16.5, −15.1) | 2009–2019 | −4.2 (−5.4, −3.1) |
| HEV | 1990–2019 | −6.9 (−7.5, −6.4) | 1990–1999 | −4.1 (−4.8, −3.5) | 1999–2008 | −12.8 (−13.8, −11.7) | 2008–2019 | −4.3 (−5.3, −3.2) |
ASIR, age-standardized incidence rates; ASMR, age-standardized mortality rates; AAPC, average annual percent of change; APC, estimated annual percent of change; HAV, hepatitis A; HBV, hepatitis B; HCV, hepatitis C; HEV, Hepatitis E.